Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 October 2005

Cost effectiveness of positron emission tomography in Canada.

J Scott Sloka, Peter D Hollett

Med Sci Monit 2005; 11(10): PH1-6 :: ID: 430329

Abstract

BACKGROUND: Positron emission tomography (PET) has been shown to be costeffective for the staging of stage I and II breast cancer, recurrent colorectal cancer and non smallcell lung cancer. This study determines a required catchment size for the management of these three cancersbased on a breakeven analysis. MATERIAL/METHODS: Cost effectiveness analysis is used to determine thecost savings of introducing PET into the diagnostic algorithm for the staging of stage I and II breastcancer, recurrent colorectal cancer and non small cell lung cancer. The cost savings for these cancersare used to calculate a required catchment area for the installation of a PET center with cyclotron.RESULTS: The aggregate estimated "breakeven" cost of a PET study would be dollars 2195, well below theexpected cost per study. In order to break even, each PET device would require 740 new cases per year.For a general representative population, one person per 766 may benefit from a PET scan if a PET studywas included in the diagnostic algorithm for all three cancers. Finally, a calculated catchment sizeof 567,000 people would support the use of a PET center with cyclotron CONCLUSIONS: The use of PET forthe staging of cancer appears to be cost effective in most jurisdictions in Canada.

Keywords: Canada, Breast Neoplasms - radionuclide imaging, Carcinoma, Non-Small-Cell Lung - radionuclide imaging, Colorectal Neoplasms - radionuclide imaging, Cost-Benefit Analysis, Lung Neoplasms - radionuclide imaging, Positron-Emission Tomography - economics

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750